LCN2 and systemic sclerosis: NGAL serum levels does not show significant differences (p > 0.05) in SSc patients with early (21.28 ± 2.85 pg/ml), active (21.09 ± 2.94 pg/ml) and late (20.31 ± 2.41 pg/ml) NVC pattern.